CYP27A1 and cholestasis: The results showed that the protein expression of FXR and CYP27A1 were downregulated in the model group, but were upregulated after Q7R administration (Figure 5), indicating that Q7R can effectively alleviate the bile acid synthesis disorder caused by the disease, alleviating the cholestasis-induced damage to hepatocytes.